✦ LIBER ✦

93 POSTER Phase I assessment of mechanistic pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase

✍ Scribed by A. Chakravarty; V.B. Shinde; K. Galvin; L. Silverman; B. Stringer; H. Danaee; O. Eton; M. Manfredi; J. Ecsedy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

281 POSTER Phase I and pharmacokinetic s

✍ E. Dees; J.R. Infante; R.B. Cohen; B. O'Neil; H. Burris; M. von Mehren; G. Gray; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

279 POSTER MLN8054, a selective inhibito

✍ A. Cervantes; T. Macarulla; S. Roselló; E. Rodríguez-Braun; J. Baselga; J. Taber 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

285 POSTER MLN8237, an oral selective Au

✍ J. Tabernero Caturla; A. Cervantes; E. Elez; T. Macarulla; S. Roselló; E. Rodríg 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

285 POSTER AT7519, a selective small mol

✍ J. Lyons; P. Sweeney; V. Lock; M. Squires; N. Thompson; N. Gallagher 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

280 POSTER Phase I study of the safety,

✍ J. Infante; E.C. Dees; R.B. Cohen; H. Burris; B. O'Neil; P. Murphy; Y. Lee; J. P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Preclinical pharmacokinetic/pharmacodyna

✍ Palani, Santhosh; Patel, Mayankbhai; Huck, Jessica; Zhang, Mengkun; Balani, Sure 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 365 KB